S. Galli, J. Kalesnikoff, M. Grimbaldeston, A. Piliponsky, and C. Williams, MAST CELLS AS ???TUNABLE??? EFFECTOR AND IMMUNOREGULATORY CELLS: Recent Advances, Annual Review of Immunology, vol.23, issue.1, pp.749-786, 2005.
DOI : 10.1146/annurev.immunol.21.120601.141025

Y. Bounab, A. Getahun, J. Cambier, and M. Daëron, Phosphatase regulation of immunoreceptor signaling in T cells, B cells and mast cells, Current Opinion in Immunology, vol.25, issue.3, 2013.
DOI : 10.1016/j.coi.2013.04.001

M. Riccaboni, I. Bianchi, and P. Petrillo, Spleen tyrosine kinases: biology, therapeutic targets and drugs, Drug Discovery Today, vol.15, issue.13-14, pp.517-530, 2010.
DOI : 10.1016/j.drudis.2010.05.001

D. Cruz, O. Uckun, and F. , Targeting Spleen Tyrosine Kinase (Syk) for Treatment of Human Disease, J Pharm Drug Deliv Res, vol.01, pp.2325-9604, 2012.

E. Meltzer, R. Berkowitz, and E. Grossbard, An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment, Journal of Allergy and Clinical Immunology, vol.115, issue.4, pp.791-796, 2005.
DOI : 10.1016/j.jaci.2005.01.040

P. Norman, A novel Syk kinase inhibitor suitable for inhalation: R-343(?) ??? WO-2009031011, Expert Opinion on Therapeutic Patents, vol.12, issue.10, pp.1469-1472, 2009.
DOI : 10.1124/jpet.103.052316

E. Mazuc, B. Villoutreix, O. Malbec, T. Roumier, and S. Fleury, A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally, Journal of Allergy and Clinical Immunology, vol.122, issue.1, pp.188-194, 2008.
DOI : 10.1016/j.jaci.2008.04.026

URL : https://hal.archives-ouvertes.fr/inserm-00292498

B. Villoutreix, G. Laconde, D. Lagorce, P. Martineau, and M. Miteva, Tyrosine kinase syk non-enzymatic inhibitors and potential anti-allergic druglike compounds discovered by virtual and in vitro screening, PloS One, vol.6, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00610280

S. Dauvillier, P. Merida, M. Visintin, A. Cattaneo, and C. Bonnerot, Intracellular Single-Chain Variable Fragments Directed to the Src Homology 2 Domains of Syk Partially Inhibit Fc??RI Signaling in the RBL-2H3 Cell Line, The Journal of Immunology, vol.169, issue.5, pp.2274-2283, 2002.
DOI : 10.4049/jimmunol.169.5.2274

N. Gargano and A. Cattaneo, Rescue of a neutralizing anti-viral antibody fragment from an intracellular polyclonal repertoire expressed in mammalian cells, FEBS Letters, vol.92, issue.3, pp.537-540, 1997.
DOI : 10.1016/S0014-5793(97)01065-X

N. Gargano and A. Cattaneo, Inhibition of murine leukaemia virus retrotranscription by the intracellular expression of a phage-derived anti-reverse transcriptase antibody fragment., Journal of General Virology, vol.78, issue.10, pp.2591-2599, 1997.
DOI : 10.1099/0022-1317-78-10-2591

A. Cattaneo and S. Biocca, The selection of intracellular antibodies, Trends in Biotechnology, vol.17, issue.3, pp.115-121, 1999.
DOI : 10.1016/S0167-7799(98)01268-2

P. Philibert, A. Stoessel, W. Wang, A. Sibler, and N. Bec, A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm, BMC Biotechnology, vol.7, issue.1, pp.81-91, 2007.
DOI : 10.1186/1472-6750-7-81

URL : https://hal.archives-ouvertes.fr/inserm-00192411

L. Guglielmi, V. Denis, N. Vezzio-vié, N. Bec, and P. Dariavach, Selection for intrabody solubility in mammalian cells using GFP fusions, Protein Engineering Design and Selection, vol.24, issue.12, pp.873-881, 2011.
DOI : 10.1093/protein/gzr049

URL : https://hal.archives-ouvertes.fr/inserm-00633286

J. Li and R. Tibshirani, Finding consistent patterns: A nonparametric approach for identifying differential expression in RNA-Seq data, Statistical Methods in Medical Research, vol.43, issue.3, 2011.
DOI : 10.1214/aos/1074290335

V. Giudicelli, P. Duroux, C. Ginestoux, G. Folch, and J. Jabado-michaloud, IMGT/LIGM-DB, the IMGT(R) comprehensive database of immunoglobulin and T cell receptor nucleotide sequences, Nucleic Acids Research, vol.34, issue.90001, pp.781-784, 2006.
DOI : 10.1093/nar/gkj088

S. Dauvillier, P. Merida, M. Visintin, A. Cattaneo, and C. Bonnerot, Intracellular Single-Chain Variable Fragments Directed to the Src Homology 2 Domains of Syk Partially Inhibit Fc??RI Signaling in the RBL-2H3 Cell Line, The Journal of Immunology, vol.169, issue.5, pp.2274-2283, 2002.
DOI : 10.4049/jimmunol.169.5.2274

P. Schneider, Production of Recombinant TRAIL and TRAIL Receptor: Fc Chimeric Proteins, Methods Enzymol, vol.322, pp.325-345, 2000.
DOI : 10.1016/S0076-6879(00)22031-4

A. Shevchenko, H. Tomas, J. Havlis, J. Olsen, and M. Mann, In-gel digestion for mass spectrometric characterization of proteins and proteomes, Nature Protocols, vol.5, issue.6, 2006.
DOI : 10.1038/nprot.2006.468

A. Fisher and M. Delisa, Efficient Isolation of Soluble Intracellular Single-chain Antibodies using the Twin-arginine Translocation Machinery, Journal of Molecular Biology, vol.385, issue.1, pp.299-311, 2009.
DOI : 10.1016/j.jmb.2008.10.051

S. Demo, E. Masuda, A. Rossi, B. Throndset, and A. Gerard, Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assay, Cytometry, vol.340, issue.4, pp.340-348, 1999.
DOI : 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C

K. Asai, J. Kitaura, Y. Kawakami, N. Yamagata, and M. Tsai, Regulation of Mast Cell Survival by IgE, Immunity, vol.14, issue.6, pp.791-800, 2001.
DOI : 10.1016/S1074-7613(01)00157-1

J. Kalesnikoff, M. Huber, V. Lam, J. Damen, and J. Zhang, Monomeric IgE Stimulates Signaling Pathways in Mast Cells that Lead to Cytokine Production and Cell Survival, Immunity, vol.14, issue.6, pp.801-811, 2001.
DOI : 10.1016/S1074-7613(01)00159-5

E. Ward, D. Güssow, A. Griffiths, P. Jones, and G. Winter, Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli, Nature, vol.341, issue.6242, pp.544-546, 1989.
DOI : 10.1038/341544a0

C. Su, V. Nguyen, and M. Nei, Adaptive Evolution of Variable Region Genes Encoding an Unusual Type of Immunoglobulin in Camelids, Molecular Biology and Evolution, vol.19, issue.3, pp.205-215, 2002.
DOI : 10.1093/oxfordjournals.molbev.a004073

T. Tanaka, M. Lobato, and T. Rabbitts, Single Domain Intracellular Antibodies: A Minimal Fragment For Direct In Vivo Selection of Antigen-specific Intrabodies, Journal of Molecular Biology, vol.331, issue.5, pp.1109-1120, 2003.
DOI : 10.1016/S0022-2836(03)00836-2

J. Kalesnikoff and S. Galli, New developments in mast cell biology, Nature Immunology, vol.179, issue.11, pp.1215-1223, 2008.
DOI : 10.1038/nature07204

S. Genini, T. Nguyen, M. Malek, R. Talbot, and S. Gebert, Radiation hybrid mapping of 18 positional and physiological candidate genes for arthrogryposis multiplex congenita on porcine chromosome 5, Animal Genetics, vol.6, issue.3, pp.239-244, 2006.
DOI : 10.1159/000015095

K. Yea, H. Zhang, J. Xie, T. Jones, and G. Yang, Converting stem cells to dendritic cells by agonist antibodies from unbiased morphogenic selections, Proceedings of the National Academy of Sciences, vol.110, issue.37, pp.14966-14971, 2013.
DOI : 10.1073/pnas.1313671110

J. Xie, K. Yea, H. Zhang, B. Moldt, and L. He, Prevention of Cell Death by Antibodies Selected from Intracellular Combinatorial Libraries, Chemistry & Biology, vol.21, issue.2, pp.274-283, 2014.
DOI : 10.1016/j.chembiol.2013.12.006

U. Ravn, F. Gueneau, L. Baerlocher, M. Osteras, and M. Desmurs, Bypassing in vitro screening?next generation sequencing technologies applied to antibody display and in silico candidate selection, Nucleic Acids Res, vol.38, 2010.

K. Paz, L. Brennan, M. Iacolina, J. Doody, and Y. Hadari, Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation, Molecular Cancer Therapeutics, vol.4, issue.11, pp.1801-1809, 2005.
DOI : 10.1158/1535-7163.MCT-05-0174

H. Griffin, R. Elston, D. Jackson, A. K. Coleman, and M. , Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting, Journal of Molecular Biology, vol.355, issue.3, pp.360-378, 2006.
DOI : 10.1016/j.jmb.2005.10.077

P. Cohen, J. Mani, and D. Lane, Characterization of a new intrabody directed against the N-terminal region of human p53, Oncogene, vol.17, issue.19, pp.2445-2456, 1998.
DOI : 10.1038/sj.onc.1202190

P. Martineau, P. Jones, and G. Winter, Expression of an antibody fragment at high levels in the bacterial cytoplasm, Journal of Molecular Biology, vol.280, issue.1, pp.117-127, 1998.
DOI : 10.1006/jmbi.1998.1840

T. Tanaka, R. Williams, and T. Rabbitts, Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS, The EMBO Journal, vol.16, issue.13, pp.3250-3259, 2007.
DOI : 10.1038/sj.emboj.7601744

T. Miller, C. Zhou, S. Gines, M. Macdonald, and N. Mazarakis, A human single-chain Fv intrabody preferentially targets amino-terminal huntingtin fragments in striatal models of Huntington's disease, Neurobiology of Disease, vol.19, issue.1-2, pp.47-56, 2005.
DOI : 10.1016/j.nbd.2004.11.003

L. Cassimeris, L. Guglielmi, V. Denis, C. Larroque, and P. Martineau, Specific In Vivo Labeling of Tyrosinated ??-Tubulin and Measurement of Microtubule Dynamics Using a GFP Tagged, Cytoplasmically Expressed Recombinant Antibody, PLoS ONE, vol.7, issue.3, 2013.
DOI : 10.1371/journal.pone.0059812.s006

URL : https://hal.archives-ouvertes.fr/inserm-00815700

E. Caussinus, O. Kanca, and M. Affolter, Fluorescent fusion protein knockout mediated by anti-GFP nanobody, Nature Structural & Molecular Biology, vol.420, issue.1, pp.117-121, 2012.
DOI : 10.1093/nar/gni035

D. Butler and A. Messer, Bifunctional Anti-Huntingtin Proteasome-Directed Intrabodies Mediate Efficient Degradation of Mutant Huntingtin Exon 1 Protein Fragments, PLoS ONE, vol.3, issue.12, 2011.
DOI : 10.1371/journal.pone.0029199.t001

A. Sibler, A. Nordhammer, M. Masson, P. Martineau, and G. Trave, Nucleocytoplasmic shuttling of antigen in mammalian cells conferred by a soluble versus insoluble single-chain antibody fragment equipped with import/export signals, Experimental Cell Research, vol.286, issue.2, pp.276-287, 2003.
DOI : 10.1016/S0014-4827(03)00093-4

URL : https://hal.archives-ouvertes.fr/hal-00192416

T. Böldicke, Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER, Journal of Cellular and Molecular Medicine, vol.11, issue.43, pp.54-70, 2007.
DOI : 10.1111/j.1349-7006.2004.tb03226.x

C. Rabu, R. Mcintosh, Z. Jurasova, and L. Durrant, Glycans as targets for therapeutic antitumor antibodies, Future Oncology, vol.8, issue.8, 2012.
DOI : 10.2217/fon.12.88

F. Quintana, A. Yeste, H. Weiner, and R. Covacu, Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis, Journal of Neuroimmunology, vol.248, issue.1-2, pp.53-57, 2012.
DOI : 10.1016/j.jneuroim.2012.01.002

J. Luo, M. Emanuele, D. Li, C. Creighton, and M. Schlabach, A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene, Cell, vol.137, issue.5, pp.835-848, 2009.
DOI : 10.1016/j.cell.2009.05.006

S. Beronja, P. Janki, E. Heller, L. W. Keyes, and B. , RNAi screens in mice identify physiological regulators of oncogenic growth, Nature, vol.28, issue.7466, pp.185-190, 2013.
DOI : 10.1038/nature12464

S. Huang, M. Hölzel, T. Knijnenburg, A. Schlicker, and P. Roepman, MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-?? Receptor Signaling, Cell, vol.151, issue.5, 2012.
DOI : 10.1016/j.cell.2012.10.035

R. Kontermann, Intrabodies as therapeutic agents, Methods, vol.34, issue.2, pp.163-170, 2004.
DOI : 10.1016/j.ymeth.2004.04.002

R. Alvarez, M. Barnes, J. Gomez-navarro, M. Wang, and T. Strong, A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibodyencoding adenovirus (AD21): a phase I trial, Clin Cancer Res, vol.6, pp.3081-3087, 2000.

J. Swaminathan and C. Ehrhardt, Liposomal delivery of proteins and peptides, Expert Opinion on Drug Delivery, vol.13, issue.1, pp.1489-1503, 2012.
DOI : 10.1016/j.jconrel.2009.10.027

G. Freund, A. Sibler, D. Desplancq, M. Oulad-abdelghani, and M. Vigneron, Targeting endogenous nuclear antigens by electrotransfer of monoclonal antibodies in living cells, mAbs, vol.257, issue.4, pp.518-522, 2013.
DOI : 10.1007/s00418-011-0793-3

A. Marschall, A. Frenzel, T. Schirrmann, M. Schüngel, and S. Dubel, Targeting antibodies to the cytoplasm, mAbs, vol.106, issue.1, pp.3-16, 2011.
DOI : 10.1021/bi010248g

D. Agostino, R. Belanger, A. , and D. Jr, R (n.d.) A suggestion for using powerful and informative tests of normality, Am Stat, vol.44, pp.316-321